Your browser version may not work well with NCBI's Web applications. More information here...
1: Pharmacogenomics. 2004 Jun;5(4):439-42.Click here to read Links

VBC-Genomics Bioscience Research GmbH (LLC).

Schmidt WM.

VBC-GENOMICS Bioscience Research GmbH (LLC), Rennweg 95 B, A-1030 Vienna, Austria. research@vbc-genomics.com

Founded as a spin-off from the University of Vienna in 1999, VBC-GENOMICS Bioscience Research GmbH (LLC) has rapidly gained a strong position within the Austrian biotech scene, based on its success as a service provider in oligonucleotide synthesis and custom sequencing. In research, the company has focused on the development of diagnostic assays based on microarrays. A technical platform for amplification and analysis of DNA has been established and validated in clinical studies. In addition, the company has developed the world's first protein microarray that is certified as an in vitro diagnostic device. This microarray contains allergen components and provides a powerful assay for the profiling of numerous allergy disease-related antigens. The company also markets technological skills and array development expertise to academics and industry.

PMID: 15165180 [PubMed - indexed for MEDLINE]